E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis
Open Access
- 1 February 2012
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (2), 960-971
- https://doi.org/10.1128/aac.00731-11
Abstract
Continued research toward the development of new antifungals that act via inhibition of glycosylphosphatidylinositol (GPI) biosynthesis led to the design of E1210. In this study, we assessed the selectivity of the inhibitory activity of E1210 against Candida albicans GWT1 (Orf19.6884) protein, Aspergillus fumigatus GWT1 (AFUA_1G14870) protein, and human PIG-W protein, which can catalyze the inositol acylation of GPI early in the GPI biosynthesis pathway, and then we assessed the effects of E1210 on key C. albicans virulence factors. E1210 inhibited the inositol acylation activity of C. albicans Gwt1p and A. fumigatus Gwt1p with 50% inhibitory concentrations (IC50s) of 0.3 to 0.6 μM but had no inhibitory activity against human Pig-Wp even at concentrations as high as 100 μM. To confirm the inhibition of fungal GPI biosynthesis, expression of ALS1 protein, a GPI-anchored protein, on the surfaces of C. albicans cells treated with E1210 was studied and shown to be significantly lower than that on untreated cells. However, the ALS1 protein levels in the crude extract and the RHO1 protein levels on the cell surface were found to be almost the same. Furthermore, E1210 inhibited germ tube formation, adherence to polystyrene surfaces, and biofilm formation of C. albicans at concentrations above its MIC. These results suggested that E1210 selectively inhibited inositol acylation of fungus-specific GPI which would be catalyzed by Gwt1p, leading to the inhibition of GPI-anchored protein maturation, and also that E1210 suppressed the expression of some important virulence factors of C. albicans, through its GPI biosynthesis inhibition.Keywords
This publication has 67 references indexed in Scilit:
- Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and FusariosisAntimicrobial Agents and Chemotherapy, 2011
- In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and MoldsAntimicrobial Agents and Chemotherapy, 2011
- In Vitro Activity of Micafungin against Planktonic and Sessile Candida albicans IsolatesAntimicrobial Agents and Chemotherapy, 2009
- Aspergillus fumigatus Forms Biofilms with Reduced Antifungal Drug Susceptibility on Bronchial Epithelial CellsAntimicrobial Agents and Chemotherapy, 2008
- Complementary Adhesin Function in C. albicans Biofilm FormationCurrent Biology, 2008
- Gene Overexpression/Suppression Analysis of Candidate Virulence Factors of Candida albicansEukaryotic Cell, 2008
- Eap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In VivoEukaryotic Cell, 2007
- Comprehensive Analysis of Glycosylphosphatidylinositol-Anchored Proteins in Candida albicansEukaryotic Cell, 2007
- Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulenceInternational Journal of Medical Microbiology, 2006
- Function of Candida albicans Adhesin Hwp1 in Biofilm FormationEukaryotic Cell, 2006